Implementing clinical pathways to enable early diagnosis and treatment of wild-type transthyretin amyloid cardiomyopathy. Muller SA, Oerlemans MIFJ. Eur J Heart Fail 2023;25:854-856.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Muller SA, Oerlemans MIFJ. Implementing clinical pathways to enable early diagnosis and treatment of wild-type transthyretin amyloid cardiomyopathy. Eur J Heart Fail 2023;25:854-856.
PMID: 37191114